Allen WL - Search Results

1

Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer.

Stevenson L, Allen WL, Turkington R, Jithesh PV, Proutski I, Stewart G, Lenz HJ, Van Schaeybroeck S, Longley DB, Johnston PG. Stevenson L, et al. Among authors: allen wl. Clin Cancer Res. 2012 Oct 1;18(19):5412-26. doi: 10.1158/1078-0432.CCR-12-1780. Epub 2012 Aug 2. Clin Cancer Res. 2012. PMID: 22859720 Free PMC article.

2

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer.

Turkington RC, Longley DB, Allen WL, Stevenson L, McLaughlin K, Dunne PD, Blayney JK, Salto-Tellez M, Van Schaeybroeck S, Johnston PG. Turkington RC, et al. Among authors: allen wl. Cell Death Dis. 2014 Feb 6;5(2):e1046. doi: 10.1038/cddis.2014.10. Cell Death Dis. 2014. PMID: 24503538 Free PMC article.

3

The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.

Longley DB, Allen WL, McDermott U, Wilson TR, Latif T, Boyer J, Lynch M, Johnston PG. Longley DB, et al. Among authors: allen wl. Clin Cancer Res. 2004 May 15;10(10):3562-71. doi: 10.1158/1078-0432.CCR-03-0532. Clin Cancer Res. 2004. PMID: 15161716

4

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG. Maxwell PJ, et al. Cancer Res. 2003 Aug 1;63(15):4602-6. Cancer Res. 2003. PMID: 12907638

5

Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.

McDermott U, Longley DB, Galligan L, Allen W, Wilson T, Johnston PG. McDermott U, et al. Cancer Res. 2005 Oct 1;65(19):8951-60. doi: 10.1158/0008-5472.CAN-05-0961. Cancer Res. 2005. PMID: 16204068

6

ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer.

Van Schaeybroeck S, Kalimutho M, Dunne PD, Carson R, Allen W, Jithesh PV, Redmond KL, Sasazuki T, Shirasawa S, Blayney J, Michieli P, Fenning C, Lenz HJ, Lawler M, Longley DB, Johnston PG. Van Schaeybroeck S, et al. Cell Rep. 2014 Jun 26;7(6):1940-55. doi: 10.1016/j.celrep.2014.05.032. Epub 2014 Jun 12. Cell Rep. 2014. PMID: 24931611 Free article.

7

The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG. Longley DB, et al. Among authors: allen wl. Cancer Res. 2002 May 1;62(9):2644-9. Cancer Res. 2002. PMID: 11980662

8

Role of genomic markers in colorectal cancer treatment.

Allen WL, Johnston PG. Allen WL, et al. J Clin Oncol. 2005 Jul 10;23(20):4545-52. doi: 10.1200/JCO.2005.19.752. J Clin Oncol. 2005. PMID: 16002846 Review.

9

Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.

Allen WL, Johnston PG. Allen WL, et al. Pharmacogenomics. 2005 Sep;6(6):603-14. doi: 10.2217/14622416.6.6.603. Pharmacogenomics. 2005. PMID: 16143000 Review.

10

Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C, Johnston PG. Boyer J, et al. Among authors: allen wl. Cancer Res. 2006 Mar 1;66(5):2765-77. doi: 10.1158/0008-5472.CAN-05-2693. Cancer Res. 2006. PMID: 16510598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters